Hepatitis D, Chronic Clinical Trial
Official title:
National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)
This prospective, multicenter, observational study will assess the prevalence of chronic hepatitis D in patients with chronic hepatitis B in Romania and evaluate the efficacy of Pegasys (peginterferon alfa-2a) in patients with chronic hepatitis D. Eligible patients treated with Pegasys according to current medical practice will be followed until 24 weeks after the end of treatment.
n/a
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05461170 -
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
|
Phase 2 | |
Active, not recruiting |
NCT04535544 -
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
|
Phase 2 | |
Completed |
NCT02732639 -
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
|
Phase 3 | |
Completed |
NCT02731131 -
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
|
Phase 2 | |
Completed |
NCT02765802 -
A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
|
Phase 2 | |
Active, not recruiting |
NCT05229991 -
Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
|
Phase 3 | |
Active, not recruiting |
NCT03105310 -
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
|
Phase 2 | |
Recruiting |
NCT04166266 -
Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
|
||
Completed |
NCT01088659 -
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
|
Phase 3 | |
Completed |
NCT00686790 -
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
|
Phase 3 | |
Completed |
NCT02876419 -
A Long Term Follow-up Study of Patients From the REP 301 Protocol
|